A5022018590- Inflammatory Bowel Disease
- Microscopic Colitis
- Contact Dermatitis and Allergies
- COVID-19 Impact on Reproduction
- COVID-19 and healthcare impacts
- Pharmaceutical studies and practices
- Eosinophilic Esophagitis
- Drug-Induced Adverse Reactions
- Food Allergy and Anaphylaxis Research
- Viral Infections and Outbreaks Research
Thomas Jefferson University
2024
Lenox Hill Hospital
2021
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2021
Kounis syndrome, an allergic hypersensitivity coronary disorder, is a rare but potentially life- threatening condition triggered by various allergens, including medications. We present the case of 41-year-old male with no prior cardiac history, who developed syndrome following vancomycin administration for suspected cellulitis. The patient initially presented rash, fever, and malaise, which progressed to chest discomfort associated diaphoresis elevated troponin levels. Diagnostic...
As the inflammatory bowel disease (IBD) patient population is aging, prevalence of polypharmacy rising. However, data exploring prevalence, risk factors, and clinical outcomes associated with among older adults IBD are limited. The aim study to determine (i) (≥5 medications) potentially inappropriate medication (PIM) utilization in IBD, (ii) changes medications over time, (iii) predictors polypharmacy, (iv) impact polypharmacy/PIMs on 1-year hospitalization rates.
Ensuring equitable access to novel treatment modalities has been an ongoing challenge throughout the SARS-CoV-2 pandemic. By implementing a monoclonal antibody (MAB) distribution plan in emergency department (ED), our health system aimed improve therapeutic more diverse patient populations and limit potential barriers referral-based outpatient infusion centers (OIC) offering same treatment. Our study attempts highlight unique role ED can play of therapeutics by evaluating association between...